Clinical Trial

A Dose-finding Study of JMKX003142 in Treatment of Renal Edema

Completed Phase 2
View on ClinicalTrials.gov →
Summary
To evaluate the safety,efficacy, and pharmacokinetic characteristics of JMKX003142 administered randomly, double-blind, placebo-controlled study in Chinese renal edema patients with inadequate response to conventional diuretic therapy.
Protocol Amendment History 5 changes
critical Trial completed 2026-08-11
notable Enrollment reduced: 216 -> 133 participants 2026-08-11
minor Trial arms changed: 4 -> 3 2026-08-11
notable Primary completion moved earlier: 2026-07-15 -> 2026-04-27 2026-08-11
minor Completion moved earlier: 2026-07-30 -> 2026-05-12 2026-08-11
Trial Details
NCT Number NCT06670534
Lead Sponsor Jemincare
Conditions Edema Secondary, Edema Leg
Enrollment 133 participants
Start Date 2025-10-17
Primary Completion 2026-04-27 (estimated)
Study Completion 2026-05-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-10